Infrequent hepatitis C virus (HCV) re-infection after sustained virological response (SVR) among current and former injection drug users (IDUS) having received treatment for HCV infection

被引：0
|
作者：
Grebely, Jason
Raffa, Jesse D.
Genoway, Kristo
Showler, Grey
Duncan, Fiona
Vijioen, Mork
Khara, Milan
DeVlaming, Stanley
Fraser, Chris
Conway, Brian
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada
[3] Vancouver Coastal Hlth, Pender Community Hlth Ctr, Vancouver, BC, Canada
[4] Cool Aid Community Hlth Ctr, Victoria, BC, Canada
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
296
引用
收藏
页码：370A / 371A
页数：2
相关论文
共 50 条
  • [31] Is treatment failure for hepatitis c virus infection in HIV-positive drug users associated with a shift in HCV genotypes?
    Soriano, V
    Pérez-Olmeda, M
    Ríos, P
    Núñez, M
    García-Samaniego, J
    González-Lahoz, J
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (04) : 465 - 466
  • [32] Health-Related Quality of Life (HRQL) in East Asian Patients with Hepatitis C Virus (HCV) Infection: The Impact of Treatment and Sustained Virologic Response (SVR)
    Younossi, Zobair M.
    Stepanova, Maria
    Henry, Linda
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    Lim, Young-Suk
    Chuang, Wan-Long
    Kao, Jia-Horng
    Van, Kinh Nguyen
    Lai, Ching-Lung
    Yuen, Man-Fung
    Chan, Henry Lik-Yuen
    Lai, Wei
    HEPATOLOGY, 2017, 66 : 395A - 396A
  • [33] EVIDENCE OF CONTINUED INJECTING DRUG USE AFTER ATTAINING SUSTAINED TREATMENT-INDUCED CLEARANCE OF THE HEPATITIS C VIRUS: IMPLICATIONS FOR RE-INFECTION
    Valerio, H. M.
    Hutchinson, S. J.
    Goldberg, D. J.
    Lewsey, J.
    Weir, A.
    Innes, H.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S520 - S521
  • [34] Follow-up studies of treatment for hepatitis C virus infection among injection drug users
    Dalgard, O
    CLINICAL INFECTIOUS DISEASES, 2005, 40 : S336 - S338
  • [35] Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users
    Cox, Joseph
    De, Prithwish
    Morissette, Carole
    Trernblay, Claude
    Stephenson, Randolph
    Allard, Robert
    Graves, Lisa
    Roy, Elise
    SOCIAL SCIENCE & MEDICINE, 2008, 66 (02) : 211 - 220
  • [36] Seroprevalence of HIV, Hepatitis B Virus, and HCV Among Injection Drug Users in Connecticut: Understanding Infection and Coinfection Risks in a Nonurban Population
    Akselrod, Hana
    Grau, Lauretta E.
    Barbour, Russell
    Heimer, Robert
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2014, 104 (09) : 1713 - 1721
  • [37] Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection
    Artenie, Andreea Adelina
    Zang, Geng
    Daniel, Mark
    Fortier, Emmanuel
    Jutras-Aswad, Didier
    Puzhko, Svetlana
    Bruneau, Julie
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 47 : 239 - 243
  • [38] Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection
    Grebely, Jason
    Genoway, Krista
    Khara, Milan
    Duncan, Fiona
    Viljoen, Mark
    Elliott, Doug
    Raffa, Jesse D.
    DeVlaming, Stanley
    Conwaya, Brian
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2007, 18 (05) : 437 - 443
  • [39] Cholangiolocellular Carcinoma in a Young Patient Who Showed Sustained Virological Response after Treatment for Hepatitis C Virus Infection
    Osawa, Mitsutaka
    Saitoh, Satoshi
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Sezaki, Hitomi
    Hosaka, Tetsuya
    Akuta, Norio
    Kobayashi, Masahiro
    Suzuki, Yoshiyuki
    Suzuki, Fumitaka
    Ikeda, Kenji
    Kinowaki, Keiichi
    Fujii, Takeshi
    Fukusato, Toshio
    Kondo, Fukuo
    Kumada, Hiromitsu
    INTERNAL MEDICINE, 2017, 56 (22) : 3033 - 3040
  • [40] Eligibility for treatment of hepatitis C virus infection among young injection drug users in three US cities
    Hagan, H
    Campbell, J
    Garfein, R
    Latka, M
    Strathdee, S
    Thomas, D
    Golub, E
    HEPATOLOGY, 2005, 42 (04) : 693A - 693A
12345